1. Home
  2. BBNX vs TOI Comparison

BBNX vs TOI Comparison

Compare BBNX & TOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Beta Bionics Inc.

BBNX

Beta Bionics Inc.

HOLD

Current Price

$15.85

Market Cap

493.1M

Sector

Health Care

ML Signal

HOLD

Logo The Oncology Institute Inc.

TOI

The Oncology Institute Inc.

HOLD

Current Price

$4.95

Market Cap

565.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BBNX
TOI
Founded
2015
2007
Country
United States
United States
Employees
423
641
Industry
Medical/Dental Instruments
Medical/Nursing Services
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
493.1M
565.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BBNX
TOI
Price
$15.85
$4.95
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
10
3
Target Price
$23.80
$6.67
AVG Volume (30 Days)
994.2K
2.2M
Earning Date
04-21-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$34.90
$30.15
Revenue Next Year
$34.63
$25.77
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.80
$2.32
52 Week High
$32.71
$6.67

Technical Indicators

Market Signals
Indicator
BBNX
TOI
Relative Strength Index (RSI) 50.51 43.73
Support Level $9.34 $4.90
Resistance Level $32.52 $5.63
Average True Range (ATR) 1.17 0.42
MACD -0.25 -0.12
Stochastic Oscillator 18.16 2.11

Price Performance

Historical Comparison
BBNX
TOI

About BBNX Beta Bionics Inc.

Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.

About TOI The Oncology Institute Inc.

The Oncology Institute Inc offers oncology care and treatment services to patients through several clinics located across the United States. It offers services such as infusion chemotherapy, oral drug chemotherapy, hospice and palliative care, autologous stem cell transplants, outpatient blood product transfusions, patient navigator programs, radiation oncology, and others on a fee or value-based model. Additionally, the company enrolls patients in clinical trials, where appropriate. The company has three operating segments: Specialty Pharmacy, Patient Services, and Clinical Trials and Other. Maximum revenue is generated from the Specialty Pharmacy segment, which operates specialty and retail pharmacies providing IV-infused, oral, injectable, and other medications for oncology treatment.

Share on Social Networks: